: Phase II study of Taxotere as first line chemotherapy for metastatic breast cancer; A National Cancer Institute of Canada Clinical Trials Group study [Abstract]
収録刊行物
-
- Proc Am Soc Clin Oncol
-
Proc Am Soc Clin Oncol 12 64 (Abst 59)-, 1993